Revolution Medicines, Inc. (RVMD)

NASDAQ: RVMD · Real-Time Price · USD

211.38

-0.20 (-0.09%)

At close: Aug 25, 2026, 4:00 PM EDT

211.75

+0.37 (0.18%)

Pre-market: Aug 26, 2026, 7:33 AM EDT

Revolution Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	-	-	11.58	35.38	29.39
Revenue Growth	-	-	-	-67.27%	20.38%	-31.62%
Cost of Revenue	1,296	987.33	592.23	419.44	253.07	186.95
Gross Profit	-1,296	-987.33	-592.23	-407.86	-217.69	-157.56
Selling, General & Admin	330.91	195.04	97.3	68.12	40.59	30.45
Operating Expenses	330.91	195.04	97.3	68.12	40.59	30.45
Operating Income	-1,627	-1,182	-689.52	-475.99	-258.28	-188.01
Interest Expense	-59.34	-24.23	-	-	-	-0.01
Interest & Investment Income	98.46	90.69	86.88	47.48	9.15	0.93
Other Non Operating Income (Expenses)	-180.16	-15.4	1.8	-0.19	-	-
EBT Excluding Unusual Items	-1,768	-1,131	-600.85	-428.69	-249.13	-187.09
Merger & Restructuring Charges	-	-	-	-11.2	-	-
Pretax Income	-1,768	-1,131	-600.85	-439.89	-249.13	-187.09
Income Tax Expense	-	-	-0.75	-3.52	-0.42	-
Net Income	-1,768	-1,131	-600.09	-436.37	-248.71	-187.09
Net Income to Common	-1,768	-1,131	-600.09	-436.37	-248.71	-187.09
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	198	190	168	113	81	73
Shares Outstanding (Diluted)	198	190	168	113	81	73
Shares Change	10.45%	13.35%	48.24%	40.34%	10.74%	32.68%
EPS (Basic)	-8.92	-5.95	-3.58	-3.86	-3.08	-2.57
EPS (Diluted)	-8.92	-5.95	-3.58	-3.86	-3.08	-2.57
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-1,232	-913.73	-567.74	-358.3	-235.22	-153.71
Free Cash Flow Per Share	-6.22	-4.81	-3.38	-3.17	-2.92	-2.11
Operating Margin	-	-	-	-4110.41%	-730.01%	-639.70%
Profit Margin	-	-	-	-3768.28%	-702.95%	-636.58%
Free Cash Flow Margin	-	-	-	-3094.14%	-664.83%	-522.99%
EBITDA	-1,618	-1,175	-683	-470.98	-254.34	-184.96
D&A For EBITDA	9.06	7.75	6.53	5.01	3.94	3.05
EBIT	-1,627	-1,182	-689.52	-475.99	-258.28	-188.01
Revenue as Reported	-	-	-	11.58	35.38	29.39

SEC Filings: 10-K · 10-Q